Merck
CN
Search Within

398276

应用筛选条件
关键词:'398276'
显示 31-37 共 37 条结果 关于 "398276" 范围 论文
A Hickel et al.
Biotechnology and bioengineering, 65(4), 425-436 (1999-10-03)
A novel recycle reactor has been designed to determine the interfacial activity of hydroxynitrile lyase in a diisopropyl ether (DIPE)/water two-phase system. The reactor provides a known interfacial area. Enzyme activity toward mandelonitrile cleavage is continuously measured in the reactor
Unimolecular metastable decompositions of 1,1,1-trifluoroisopropyl methyl ether [CF3(CH3)CHOCH3] upon electron ionization.
Susumu Tajima et al.
Rapid communications in mass spectrometry : RCM, 17(5), 503-506 (2003-02-19)
G Arivazhagan et al.
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 81(1), 172-177 (2011-07-08)
FTIR and 13C NMR spectral studies have been carried out on diisopropyl ether-propionic acid binary mixture to probe the molecular interactions and stoichiometry of complexation. Density functional theory (DFT) calculations of vibrational frequencies of pure acid and ether-acid binary mixtures
G Flesch et al.
Journal of chromatography. B, Biomedical applications, 657(1), 155-161 (1994-07-01)
A specific and sensitive liquid chromatographic assay for CGP 53,437 (I), a potent HIV protease inhibitor, is described. The method is based on a deproteinization step, followed by a liquid-liquid extraction with diisopropyl ether. Then a deprotection step of the
Cross-linked enzyme aggregates (CLEAs): stable and recyclable biocatalysts.
Sheldon RA.
Biochemical Society Transactions, 35(6) (2007)
Hans Peter H Arp et al.
Environmental science & technology, 38(20), 5405-5412 (2004-11-17)
The gasoline oxygenate methyl tert-butyl ether (MTBE) has become one of the world's mostwidespread groundwater and surface water contaminants. As a result, there has been increasing interest in the environmental behavior of MTBE and its degradation products, mainly tert-butyl formate
Ali N Saleemi et al.
International journal of pharmaceutics, 430(1-2), 56-64 (2012-03-28)
Pharmaceutical regulatory bodies require minimal presence of solvent in an active pharmaceutical ingredient (API) after crystallization. From a processing point of view bigger crystals with minimal agglomeration and uniform size distribution are preferred to avoid solvent inclusion and for improved
2/2